Table 2.
Recurrent chromosomal losses and deletions | ||||||
---|---|---|---|---|---|---|
Aguirre et al52 | Bashyam et al53 | Gysin et al51 | Heidenblad et al54 | Nowak et al55 | ||
9p | X | X | X | X | X | CDKN2A, TUSC3 |
18q | X | X | X | X | X | Smad4 |
3p | X | X | X | X | FHIT, FOXP1 | |
4q | X | X | X | X | FBXW7 | |
6q | X | X | X | X | SEC63, SASH1, LPA | |
8p | X | X | X | X | DEFB103, DEFB105 | |
17p | X | X | X | X | TP53, MKK4 | |
6p | X | X | X | |||
13q | X | X | X | GPC5 | ||
21q | X | X | X | PARD6G | ||
9q | X | X | TNFSF15 | |||
10q | X | X | CDH23 | |||
12q | X | X | DUSP6 | |||
15q | X | X | ||||
21p | X | X | ||||
22q | X | X | ||||
Xp | X | X | FMR2, ARSC1 | |||
Recurrent chromosomal gains and amplifications | ||||||
12p | X | X | X | X | KRAS2 | |
20q | X | X | X | CTSZ, NCOA3 | ||
8q | X | X | X | MYC | ||
11q | X | X | X | Cyclin D | ||
17q | X | X | X | ERBB2 | ||
7q | X | X | X | SMURF1 | ||
5p | X | X | BASP1 | |||
7p | X | X | EGFR | |||
14q | X | X | TGFB3 | |||
6p | X | X | NOTCH4 | |||
19q | X | X | AKT2, eIF3k | |||
3q | X | X |
Genes highlighted in boldface are known to be associated with pancreatic carcinoma.